eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Bayer plc

Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 26/09/2011
PIL Betaferon

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change of licence holder
Updated on 03/02/2011 and displayed until 26/09/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 20/01/2011 and displayed until 03/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 17/02/2010 and displayed until 20/01/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 27/05/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Introduction of new pack/pack size
Updated on 24/12/2008 and displayed until 27/05/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 16/07/2008 and displayed until 24/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/02/2008 and displayed until 16/07/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision
Updated on 08/06/2007 and displayed until 14/02/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 25/05/2007 and displayed until 08/06/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Changes to therapeutic indications
Updated on 06/03/2007 and displayed until 25/05/2007
Reasons for adding or updating:
  • Change to packaging
  • Change to how to administer the medicine
  • Introduction of new pack
  • Change to date of revision
Updated on 20/07/2006 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 10/03/2006 and displayed until 20/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 26/08/2004 and displayed until 10/03/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/08/2004 and displayed until 26/08/2004
Reasons for adding or updating:
  • Change to storage instructions
  • Change to date of revision
Updated on 11/12/2002 and displayed until 02/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 05/02/2002 and displayed until 11/12/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 06/07/2000 and displayed until 05/02/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   interferon beta-1b